Aduhelm represents a significant step forward in the treatment of Alzheimer’s disease, with its advanced effects and benefits making it an exciting development in the field of Alzheimer’s research.
The drug offers hope to millions of people worldwide suffering from Alzheimer’s disease,
Aduhelm (aducanumab-avwa) is a prescription medicine used to treat people with mild cognitive impairment or mild dementia,. It is the first novel therapy approved for Alzheimer’s disease since 2003.
Ajovy (fremanezumab-vfrm) is a promising new drug for the prophylactic treatment of migraines in adults.
Its advanced effects are due to its unique mechanism of action, which targets the underlying cause of migraines by blocking the release of CGRP. 1 prefilled syringe of 225 mg/1.5mL
Amondys 45 (casimersen) is an FDA-approved medication that can potentially improve the quality of life of DMD patients who have a specific mutation in exon 45 of the dystrophin gene.
Amondys 45 works by inducing exon skipping and promoting the production of truncated dystrophin, which can partially restore muscle function in affected individuals.
Amondys 45 (casimersen) is a medication used for the treatment of Duchenne muscular dystrophy (DMD) in patients who have a confirmed mutation of the DMD gene that is amenable to exon 45 skipping.
Calcort (deflazacort) is a medication used for the treatment of several conditions, e.g. asthma, arthritis, and allergies, skin, kidney, heart, digestive system, eye and blood conditions, and tumours. Calcort (deflazacort) is also used for the treatment of Duchenne muscular dystrophy (DMD).
Clenbuterol is a medication used for the treatment of people with bronchial asthma, chronic bronchitis, emphysema, acute bronchitis, or stress urinary incontinence.
Physicians sometimes prescribe Clenbuterol for off-label treatment of people suffering from ALS.
Clenbuterol was previously known under the brand name TONIL (clenbuterol).
Edaravone is a medication for the treatment of patients with amyotrophic lateral sclerosis (ALS) and acute ischaemic stroke.
This edaravone generic is available from various manufacturers. Please contact our support team to verify which form we can currently get for you. It may differ from the picture and manufacturer shown on this page.
Enspryng is a unique and advanced drug that targets the IL-6 receptor and reduces inflammation in the nervous system of individuals with NMOSD.
The drug has undergone extensive clinical trials and has been found to be effective in reducing the frequency and severity of attacks, preventing disability progression and reducing the risk of relapse.